LEXG-Lexicon Genetics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LEXG-Lexicon Genetics

LXRX 1.250

-12.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (60)	5/9/2001 11:13:02 PM
From: JFitnich	of 254

I thought this was a pretty decent article on LEXG / DGEN. Found it on the YHOO Board. Apologies if this was posted previously. www0.mercurycenter.com Nothing much new from the conf call. I intend to listen to it again, but if you caught the analyst's day presentation, you heard the majority of the information. Comment made about the "quality of earnings". This quarter showed more recurring revenues, (LexVision revenue, sublicense fees-IMNX), in comparison to 00 quarter last year. Cash burn for the year was raised slightly to $35MM-40MM. We're looking at a company that by my calculation still has about $4/share in cash. Money well spent IMO, I certainly don't think Matthews is going to let up on the capital investment. Especially when he's close to positive cash flow on the database end. Keep spending Arthur!!!! JF

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next